Time-Resolved Profiling: Metabolic Adaptation & Morphology-Specific Drug Response in MCF-7 spheroids

Three-dimensional (3D) tumor models exhibit drug responses that differ from conventional 2D cultures. However, how cellular metabolism dynamically evolves across culture models and during drug treatment remains poorly understood. We compared the responses of MCF-7 cells in 2D and 3D environments to 5-fluorouracil (5-FU), combining {superscript 1}H NMR cellular metabolomics with viable cell counts, the GLUT1-positive population, gene expression, ATP activity, and morphology. Principal component analysis revealed that culture dimensionality, rather than 5-FU treatment, was the primary driver of metabolic flux variation. 3D spheroids exhibited higher glycolytic flux at 72h. Importantly, this elevated glycolysis reflected a higher per-cell flux in larger spheroids rather than an increased cell number. We further observed a higher proportion of GLUT1-positive cells and increased HK2 expression in 3D culture, together with an epithelial phenotype characterized by increased CDH1 and decreased VIM expression. Functionally, 3D displayed maintaining higher cell viability, ATP activity following treatment. Together, these findings suggest that 3D architecture promotes a metabolically defensive phenotype and cellular metabolic behaviors is associated with morphology, which may inform future drug screening model selection. BlurbTime-resolved NMR metabolomics reveals that 3D culture architecture, rather than 5-FU treatment, defines the metabolic phenotype of MCF-7 cells, linking spheroid morphology with per-cell glycolytic activity, ATP preservation, and reduced chemotherapy sensitivity. Synopsis O_FIG O_LINKSMALLFIG WIDTH=197 HEIGHT=200 SRC="FIGDIR/small/740505v1_ufig1.gif" ALT="Figure 1"> View larger version (41K): org.highwire.dtl.DTLVardef@cf6b74org.highwire.dtl.DTLVardef@197a4aeorg.highwire.dtl.DTLVardef@bcb5f8org.highwire.dtl.DTLVardef@14ec1ac_HPS_FORMAT_FIGEXP M_FIG C_FIG Graphical abstract -- Time-resolved metabolic and phenotypic responses of 2D and 3D MCF-7 cultures to 5-fluorouracil. Bullet pointsO_LITime-resolved {superscript 1}H NMR cellular metabolomics combined with multilevel phenotypic readouts reveals that culture dimensionality, rather than 5-FU chemotherapy, is the dominant determinant of metabolic phenotype in MCF-7 breast cancer cells. C_LIO_LI3D spheroids develop a glycolysis-dominant metabolic state with markedly elevated GLUT1 populations and HK2 transcript, accompanied by substantially reduced sensitivity to 5-FU compared with 2D monolayers. C_LIO_LISpheroid morphology correlates with cellular metabolic flux: larger and more elongated spheroids exhibit higher glycolytic activity on a per cell, independent of spheroid cell number. C_LIO_LIThe 3D-defined metabolic state buffers ATP under 5-FU stress and reinforces an epithelial transcriptional program (CDH1{uparrow}, VIM{downarrow}), arguing that culture architecture must be considered when interpreting preclinical drug responses. C_LI